Related Experiment Video

Updated: Apr 5, 2026

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
09:10

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Published on: February 22, 2020

9.5K

Drugs to Enhance Motor Recovery After Stroke

Steven C Cramer1

  • 1From the Deparments of Neurology, Anatomy & Neurobiology, and Physical Medicine & Rehabilitation, University of California, Irvine, CA. scramer@uci.edu.

Stroke
|August 13, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
drugsmotor systemoutcomesrecoverystroke

More Related Videos

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.6K
Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
09:10

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Published on: February 22, 2020

9.5K
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.6K
Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

1.7K

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

869
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
869

Articles linked to this work by shared authors, journal, and citation graph.

Genomic insights into stroke recovery: cross-phenotype associations.

Brain communications·2026

The future of high-dose, high-intensity neurorehabilitation: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable.

International journal of stroke : official journal of the International Stroke Society·2026

Molecular biomarkers in stroke recovery: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable.

International journal of stroke : official journal of the International Stroke Society·2026

Exploring delta/alpha and theta/alpha ratios as longitudinal treatment-response biomarkers in post-stroke rehabilitation.

NeuroImage. Clinical·2026

Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.

Neurology·2026

ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

Stroke·2026

Social Determinants of Health in Early to Mid-Adulthood and Risk of Early-Onset Stroke.

Stroke·2026

Utility-Weighted Analysis of the Modified Rankin Scale: An Updated Review of Methods, Challenges, and Future Directions.

Stroke·2026

Role of Clinical Trials in Implementation Science and Organization Change: An Overview of Cluster, Stepped-Wedge, and Hybrid Effectiveness-Implementation Studies.

Stroke·2026

Immune Checkpoint B7-H3 Inhibition Reprograms Acute Neuroinflammation and Protects the Brain After Acute Ischemic Stroke.

Stroke·2026

Intervention Design for Individual Behavior Change in Stroke Prevention Trials.

Stroke·2026

Cilostazol Treatment for Intracerebral Hemorrhage: Targeting Dural Lymphatics.

Stroke·2026

One syndrome, many diseases: toward precision pharmacotherapy in acute respiratory distress syndrome.

Frontiers in pharmacology·2026

Use of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Stallions: First Case Reports.

Reproduction in domestic animals = Zuchthygiene·2026

Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review.

Clinical, cosmetic and investigational dermatology·2026

Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients.

Bioinformation·2026

Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.

Frontiers in pharmacology·2026

Opioid receptor agonist-antagonists in pain management: receptor specific mechanisms, dose response relationships, and clinical combination strategies.

Frontiers in pain research (Lausanne, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us